Purified Protein Derivative (PPD) Tuberculin for the U.S. Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), National Veterinary Services Laboratories (NVSL)

The USDA, Agricultural Marketing Service intends to award a single-award Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract to Zoetis, Inc. located at 10 Sylvan Way, Parsippany, NJ 07054-3825. The period of performance for the contract is anticipated to be 02/16/2025 – 02/15/2030. The scope of the IDIQ contract is for three (3) vial sizes (volumes of 10 ml, 5 ml, or 1 ml) of Purified Protein Derivative (PPD) Tuberculin for the U.S. Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), National Veterinary Services Laboratories (NVSL), Ames, Iowa, for use in determining whether animals are infected with bovine tuberculosis. The Mycobacterium bovis PPD Tuberculin must be of current production. To meet program requirements, the delivery requirements specified must be met. It is highly important that the PPD Tuberculin possess the maximum uniformity possible from the standpoint of specificity and potency. Therefore, exacting compliance with uniform methods and materials in preparing, storing, diluting, testing, bottling, and shipping is essential. Only facilities that are licensed and/or inspected and approved by the USDA for production of PPD Tuberculin shall be used. Colorado Serum Company is the only licensed manufacturer in the US. Zoetis is the contractor for the Mycobacterium bovis PPD used in the caudal fold test. Zoetis subcontracts to Colorado Serum Company to supply this product to the USDA. The applicable NAICS code for this requirement is 325413 In Vitro Diagnostic Substance Manufacturing with a small business size standard of 1,250 employees . The following Federal Acquisition Regulation (FAR) provisions and clauses apply to this acquisition: FAR 52.202-1 Definitions; FAR 52.203-17 Contractor Employee Whistleblower Rights and Requirement To Inform Employees of Whistleblower Rights; FAR 52.204-7 System for Award Management; FAR 52.209-6 Protecting the Government's Interests when Subcontracting with Contractors Debarred, Suspended or Proposed for Debarment; FAR 52.212-1 Instructions to Offers-Commercial Items; FAR 52.212-4 Contract Terms and Conditions- Commercial Items; FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes of Executive Orders-Commercial Items; FAR 52.216-18 Ordering; FAR 52.216-19 Order Limitations; FAR 52.222-3 Convict Labor; FAR 52.222-19 Child Labor - Cooperation with Authorities and Remedies; FAR 52.222-21 Prohibition of Segregated Facilities; FAR 52.222-26, Equal Opportunity Employment; FAR 52.222-35 Equal Opportunity for Veterans; FAR 52.222-36 Affirmative Action for Workers with Disabilities; FAR 52.222-37 Employment Reports on Veterans; FAR 52.222-40 Notification of Employee Rights Under the National Labor Relations Act; FAR 52.222-50 Combating Trafficking in Persons; FAR 52.222-54 Employment Eligibility Verification; FAR 52.225-13 Restrictions on Certain Foreign Purchases; FAR 52.225-25 Prohibitions on Contracting with Entities Engaging in Certain Activities or Transactions Relating to Iran-Reps and Certs; FAR 52.232-39 Unenforceability of Unauthorized Obligations; FAR 52.233-2 Service of Protest; FAR 52.233-3 Protest After Award; FAR 52.233-4 Applicable Law for Breach of Contract; FAR 52.252-1 Solicitations Provisions Incorporated by Reference; and FAR 52.252-2 Clauses Incorporated by Reference. This is a notice of intent and is not a request for competitive quotations. Award of the contract is estimated to be January 13, 2025. Questions concerning this acquisition must be in writing and directed to the Contract Specialist, Matthew Phillips via e-mail at [email protected]. Responses must be received by 12:00 P.M. Central Time on Monday, December 9, 2024, and must include detailed information on your product or service. Phone calls will not be accepted.